AzTrials
AzTrials

CommunicationPriorityNCT01976221

Priority Setting and Waiting Time Decision in the Referral Process, How and by Whom?

An observational study of Communication, run by University of Bergen at 1 site in Norway.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The referral letter is used for different purposes: a request for a special diagnostic assessment or medical treatment that the GP cannot perform for the patient, an invitation to have a second opinion about a clinical problem or a wish for mutual responsibility for the medical handling. Read more about this study

Who is it for?
Ages 25 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Communication
How many people
0 participants
Where
1 siteNorway
Study dates
Jan 2016to 10 Oct 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: General practitioners referring to Stavanger University Hospital

Who may be able to join

  • All the 300 GPs referring to Stavanger University Hospital who participate in one of the 58 CPD groups in South Rogaland County and who agree to participate in the study are included.

Who cannot join

  • GPs not willing to participate

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Stavanger University Hospital

    Stavanger, 4001

Other trials in Norway

About this study

Official title: Priority Setting and Waiting Time Decision in the Referral Process, How and by Whom? A Prospective Cluster Randomized Controlled Trial on the Effects of an Education Program in Priority Setting and Waiting Time Decision in Referrals

The referral letter is used for different purposes: a request for a special diagnostic assessment or medical treatment that the GP cannot perform for the patient, an invitation to have a second opinion about a clinical problem or a wish for mutual responsibility for the medical handling. The individual referral rate between GPs varies greatly, and is an important determinant of secondary care utilization. We wanted to study the various elements and factors having an impact on the referral process, from the moment the GP decides to refer the patient until the hospital consultant assess the referral and prioritise the patient for further investigation or treatment. How and why are we, the GPs who refer, so different? We wanted to

  1. identify and describe general practitioners' reflections on and attitudes to the referral process and cooperation with hospital specialists
  2. identify and describe hospital consultants' reflections on and attitudes to the referral process and cooperation with general practitioners
  3. identify typologies characterising GPs in the referral practice
Read the detailed description

Design and Methods:

We did two qualitative and one quantitative study. The first was a focus group study with GPs in CPD groups, the second an individual study with hospital consultants, both analyses by using systematic text condensation. The third was a quantitative registration of impressions, facts and feelings in the referral process using a principal component analysis to find typologies for GPs who refer to hospital.

Participants:

GPs referring to Stavanger University Hospital. Hospital consultants at Stavanger University Hospital.

Intervention: No intervention was performed.

Time schedule:

Data Collection finished May 2014.

Conditions
Communication
Keywords
Comprehensive referrals, Appropriate referring, Priority setting, Waiting time in hospital
Medical subject headings
Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01976221
Study groupRoleWhat they receive
PrioritizationTeam-based multifaceted interactive training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Use of priority setting and waiting time indication in referrals

    The use of priority setting and waiting time in referrals will be recorded before and after an intervention with group training for general practitioners

    Measured: 1 year

Secondary outcomes (1)
  1. Referral rates

    The referral rates may be reduced by higher awareness of non-prioritized medical conditions. The use of priority setting and waiting time according to the national prioritization guidelines can give a higher correlation between GPs and hospital consultants about priority setting and waiting time.

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Nov 2013 (estimated)
  2. Study startJan 2016
  3. Primary completionJan 2016
  4. Study completion10 Oct 2018 (estimated)

Why it stopped: Study withdrawn

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01976221
Sponsor's protocol ID
REK2013/1762
Acronym
Priority
Status last verified
Sep 2021
First submitted
17 Oct 2013
Last updated
1 Oct 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Thorsen O, Hartveit M, Baerheim A. General practitioners' reflections on referring: an asymmetric or non-dialogical process? Scand J Prim Health Care. 2012 Dec;30(4):241-6. doi: 10.3109/02813432.2012.711190. Epub 2012 Oct 10.

    PubMed 23050793

Questions about this trial

What is this clinical trial studying?

An observational study of Communication, run by University of Bergen at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 1 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Use of priority setting and waiting time indication in referrals (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01976221, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in